Elicia 4 Tablet

Introduction

Elicia is a prescription medication that contains the active ingredient Blonanserin. It is available under the brand name Elicia. This medication is primarily used in the treatment of certain mental health conditions.

Uses

Elicia is prescribed for the management of schizophrenia, a chronic mental disorder characterized by distorted thinking, hallucinations, and difficulty in distinguishing between reality and imagination. It helps to reduce symptoms such as delusions, paranoia, and disorganized thinking commonly associated with this condition.

Dosage and Administration

Elicia should be taken exactly as prescribed by your healthcare provider. The dosage may vary depending on your individual condition and response to treatment. It is typically taken once daily, with or without food. Do not crush or chew the tablet; swallow it whole with a glass of water.

Mechanism of Action

Blonanserin, the active ingredient in Elicia, works by blocking certain receptors in the brain, particularly dopamine receptors. By inhibiting the activity of dopamine, a neurotransmitter involved in regulating mood and behavior, Blonanserin helps to restore the balance of chemicals in the brain and alleviate symptoms of schizophrenia.

Side Effects

Common side effects may include drowsiness, dizziness, dry mouth, constipation, and weight gain. These side effects are usually mild and temporary. However, if any of these side effects persist or worsen, consult your healthcare provider.

In rare cases, Elicia may cause more serious side effects such as extrapyramidal symptoms (e.g., muscle stiffness, tremors), neuroleptic malignant syndrome (NMS), and an increased risk of seizures. If you experience any unusual or severe side effects, seek immediate medical attention.

Drug Interactions

Elicia may interact with other medications, including antidepressants, anticonvulsants, and certain antihistamines. These interactions can potentially increase the risk of side effects or reduce the effectiveness of either medication. Inform your healthcare provider about all the medications you are currently taking to avoid potential interactions.

Precautions

Before taking Elicia, inform your healthcare provider about any existing medical conditions, including liver or kidney problems, heart disease, or a history of seizures. This medication may not be suitable for everyone, and your healthcare provider will consider your medical history before prescribing it.

Elicia should be used with caution in elderly patients, as they may be more sensitive to the side effects of this medication. It is also not recommended for use during pregnancy or while breastfeeding, as the safety of Blonanserin in these situations has not been established.

Storage

Patient Tips

• Take Elicia at the same time each day to help establish a routine.
• Do not stop or change the dosage of this medication without consulting your healthcare provider.
• Avoid consuming alcohol while taking Elicia, as it may increase the risk of side effects.
• Be cautious when performing tasks that require alertness, such as driving or operating machinery, as Elicia may cause drowsiness.
• If you have any concerns or questions about your treatment, do not hesitate to reach out to your healthcare provider for guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Ethotoin (Professional Patient Advice) Professional Information (A-Z Drug Facts) (Drugs.com) [Accessed 7 Jun. 2024] (online) Available at:
• Grapefruit (MedlinePlus) [Accessed 21 Jun. 2024] (online) Available at:
• Murasaki M, Inoue Y, Nakamura H, Kinoshita T. Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies. Ann Gen Psychiatry. 2021 Sep 7;20(1):41. doi: 10.1186/s12991-021-00361-3. [Accessed 19 Jun. 2024] Available at:
• Inoue Y, Tsuchimori K, Nakamura H. Safety and effectiveness of oral blonanserin for schizophrenia: A review of Japanese post-marketing surveillances. J Pharmacol Sci. 2021 Jan;145(1):42-51. doi: 10.1016/j.jphs.2020.09.006. Epub 2020 Oct 8. [Accessed 17 Jun. 2024] Available at: